BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16951194)

  • 1. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
    Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
    Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
    Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
    FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase as a molecular target of cancer chemotherapy.
    Simizu S; Ishida K; Osada H
    Cancer Sci; 2004 Jul; 95(7):553-8. PubMed ID: 15245589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of heparanase in cancer and inflammation.
    Vlodavsky I; Beckhove P; Lerner I; Pisano C; Meirovitz A; Ilan N; Elkin M
    Cancer Microenviron; 2012 Aug; 5(2):115-32. PubMed ID: 21811836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers.
    Sletten ET; Loka RS; Yu F; Nguyen HM
    Biomacromolecules; 2017 Oct; 18(10):3387-3399. PubMed ID: 28846389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive small molecule fluorogenic probe for human heparanase.
    Liu J; Schleyer KA; Bryan TL; Xie C; Seabra G; Xu Y; Kafle A; Cui C; Wang Y; Yin K; Fetrow B; Henderson PKP; Fatland PZ; Liu J; Li C; Guo H; Cui L
    Chem Sci; 2020 Oct; 12(1):239-246. PubMed ID: 34163592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and bioassay of β-(1,4)-D-mannans as potential agents against Alzheimer's disease.
    Jiang RW; Du XG; Zhang X; Wang X; Hu DY; Meng T; Chen YL; Geng MY; Shen JK
    Acta Pharmacol Sin; 2013 Dec; 34(12):1585-91. PubMed ID: 24241344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review.
    Jin JO; Yadav D; Madhwani K; Puranik N; Chavda V; Song M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects of marine compounds blocking the nuclear factor kappa B signaling pathway.
    Wei J; Liu Y; Teng F; Li L; Zhong S; Luo H; Huang Z
    Mol Biol Rep; 2022 Oct; 49(10):9975-9995. PubMed ID: 35674876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics.
    Parate S; Kumar V; Danishuddin ; Hong JC; Lee KW
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34156395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.
    Mohan CD; Hari S; Preetham HD; Rangappa S; Barash U; Ilan N; Nayak SC; Gupta VK; Basappa ; Vlodavsky I; Rangappa KS
    iScience; 2019 May; 15():360-390. PubMed ID: 31103854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTC clusters induced by heparanase enhance breast cancer metastasis.
    Wei RR; Sun DN; Yang H; Yan J; Zhang X; Zheng XL; Fu XH; Geng MY; Huang X; Ding J
    Acta Pharmacol Sin; 2018 Aug; 39(8):1326-1337. PubMed ID: 29417941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats.
    Changyaleket B; Chong ZZ; Dull RO; Nanegrungsunk D; Xu H
    J Neuroinflammation; 2017 Jul; 14(1):137. PubMed ID: 28720149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic platinum through glycan targeting.
    Peterson EJ; Daniel AG; Katner SJ; Bohlmann L; Chang CW; Bezos A; Parish CR; von Itzstein M; Berners-Price SJ; Farrell NP
    Chem Sci; 2017 Jan; 8(1):241-252. PubMed ID: 28451171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocculus hirsutus: Molecular Docking to Identify Suitable Targets for Hepatocellular Carcinoma by In silico Technique.
    Thavamani BS; Mathew M; Dhanabal SP
    Pharmacogn Mag; 2016 May; 12(Suppl 3):S350-2. PubMed ID: 27563224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiosuppressive properties of marine-derived compounds-a mini review.
    Yue PY; Leung HM; Li AJ; Chan TN; Lum TS; Chung YL; Sung YH; Wong MH; Leung KS; Zeng EY
    Environ Sci Pollut Res Int; 2017 Apr; 24(10):8990-9001. PubMed ID: 26520098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix as target for antitumor therapy.
    Harisi R; Jeney A
    Onco Targets Ther; 2015; 8():1387-98. PubMed ID: 26089687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
    Chiodelli P; Bugatti A; Urbinati C; Rusnati M
    Molecules; 2015 Apr; 20(4):6342-88. PubMed ID: 25867824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
    Hammond E; Khurana A; Shridhar V; Dredge K
    Front Oncol; 2014; 4():195. PubMed ID: 25105093
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.